La presentazione è in caricamento. Aspetta per favore

La presentazione è in caricamento. Aspetta per favore

Long-Term Outcome to First-Line Imatinib according to 2013 European LeukemiaNet Response Criteria: a GIMEMA CML WP Analysis by Fausto Castagnetti, Gabriele.

Presentazioni simili


Presentazione sul tema: "Long-Term Outcome to First-Line Imatinib according to 2013 European LeukemiaNet Response Criteria: a GIMEMA CML WP Analysis by Fausto Castagnetti, Gabriele."— Transcript della presentazione:

1 Long-Term Outcome to First-Line Imatinib according to 2013 European LeukemiaNet Response Criteria: a GIMEMA CML WP Analysis by Fausto Castagnetti, Gabriele Gugliotta, Massimo Breccia, Fabio Stagno, Alessandra Iurlo, Francesco Albano, Elisabetta Abruzzese, Bruno Martino, Luciano Levato, Tamara Intermesoli, Patrizia Pregno, Giuseppe Rossi, Filippo Gherlinzoni, Pietro Leoni, Francesco Cavazzini, Dario Ferrero, Emilio Usala, Monica Bocchia, Mario Tiribelli, Enrico Montefusco, Simona Sica, Claudia Venturi, Simona Soverini, Michele Cavo, Giuliana Alimena, Giovanni Martinelli, Fabrizio Pane, Giuseppe Saglio, Michele Baccarani, and Gianantonio Rosti Blood Volume 126(23):2792-2792 December 3, 2015 ©2015 by American Society of Hematology

2 Fausto Castagnetti et al. Blood 2015;126:2792 ©2015 by American Society of Hematology

3 Fausto Castagnetti et al. Blood 2015;126:2792 ©2015 by American Society of Hematology

4 Fausto Castagnetti et al. Blood 2015;126:2792 ©2015 by American Society of Hematology


Scaricare ppt "Long-Term Outcome to First-Line Imatinib according to 2013 European LeukemiaNet Response Criteria: a GIMEMA CML WP Analysis by Fausto Castagnetti, Gabriele."

Presentazioni simili


Annunci Google